Urinary retention with misuse of "ecstasy".

Suppr

超能文献

作者信息

Bryden A A, Rothwell P J, O'Reilly P H

机构信息

Stepping Hill Hospital, Stockport, Cheshire.

出版信息

BMJ. 1995 Feb 25;310(6978):504. doi: 10.1136/bmj.310.6978.504a.

DOI:10.1136/bmj.310.6978.504a

PMID:7888894

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2548878/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ede/2548878/df1e7853391f/bmj00581-0032-a.jpg

相似文献

Urinary retention with misuse of "ecstasy".

BMJ. 1995 Feb 25;310(6978):504. doi: 10.1136/bmj.310.6978.504a.

[Ecstasy: a forgotten drug].

Aten Primaria. 1998 Feb 28;21(3):180.

Designer drugs. Assess & manage patients intoxicated with ecstasy, GHB or rohypnol--the three most commonly abused designer drugs.

JEMS. 2001 Jun;26(6):84-7, 90-3; quiz 94.

Misuse of ecstasy.

BMJ. 1992 Aug 1;305(6848):310. doi: 10.1136/bmj.305.6848.310-a.

Misuse of ecstasy.

BMJ. 1992 Aug 1;305(6848):309. doi: 10.1136/bmj.305.6848.309-a.

Misuse of ecstasy.

BMJ. 1992 Aug 1;305(6848):310. doi: 10.1136/bmj.305.6848.310.

Misuse of ecstasy.

BMJ. 1992 Aug 1;305(6848):309. doi: 10.1136/bmj.305.6848.309.

The agony and the ecstasy: acute urinary retention after MDMA abuse.

BJU Int. 2003 Jan;91(1):123. doi: 10.1046/j.1464-410x.2003.04018.x.

Misuse of ecstasy.

BMJ. 1992 Aug 1;305(6848):309-10. doi: 10.1136/bmj.305.6848.309-b.

[Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].

Nervenarzt. 1997 Nov;68(11):922-3.

引用本文的文献

Ecstasy (MDMA) and its effects on kidneys and their treatment: a review.

Iran J Basic Med Sci. 2016 Nov;19(11):1151-1158.

Nephrotoxic effects of designer drugs: synthetic is not better!

Nat Rev Nephrol. 2014 Jun;10(6):314-24. doi: 10.1038/nrneph.2014.44. Epub 2014 Mar 25.

Urological complications of illicit drug use.

Nat Rev Urol. 2014 Mar;11(3):169-77. doi: 10.1038/nrurol.2014.22. Epub 2014 Feb 18.

Neurogenic bladder and chronic urinary retention associated with MDMA abuse.

J Med Toxicol. 2008 Jun;4(2):106-8. doi: 10.1007/BF03160964.

Drug-induced urinary retention: incidence, management and prevention.

Drug Saf. 2008;31(5):373-88. doi: 10.2165/00002018-200831050-00002.

Spontaneous versus precipitated AUR: the same?

World J Urol. 2006 Sep;24(4):354-9. doi: 10.1007/s00345-006-0089-8.

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

Drug Saf. 1996 Aug;15(2):107-15. doi: 10.2165/00002018-199615020-00003.

本文引用的文献

Subjective reports of the effects of MDMA in a clinical setting.

J Psychoactive Drugs. 1986 Oct-Dec;18(4):319-27. doi: 10.1080/02791072.1986.10472364.

Bladder outflow obstruction secondary to intravenous amphetamine abuse.

Br J Urol. 1989 Sep;64(3):320-1. doi: 10.1111/j.1464-410x.1989.tb06028.x.

'Designer drugs'. Recognizing and managing their toxic effects.

Postgrad Med. 1992 Jun;91(8):169-71, 175-6. doi: 10.1080/00325481.1992.11701371.

Ecstasy and the dance of death.

BMJ. 1992 Jul 4;305(6844):5-6. doi: 10.1136/bmj.305.6844.5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Urinary retention with misuse of "ecstasy".

BMJ. 1995 Feb 25;310(6978):504. doi: 10.1136/bmj.310.6978.504a.

[Ecstasy: a forgotten drug].

Aten Primaria. 1998 Feb 28;21(3):180.

Designer drugs. Assess & manage patients intoxicated with ecstasy, GHB or rohypnol--the three most commonly abused designer drugs.

JEMS. 2001 Jun;26(6):84-7, 90-3; quiz 94.

Misuse of ecstasy.

BMJ. 1992 Aug 1;305(6848):310. doi: 10.1136/bmj.305.6848.310-a.

Misuse of ecstasy.

BMJ. 1992 Aug 1;305(6848):309. doi: 10.1136/bmj.305.6848.309-a.

Misuse of ecstasy.

BMJ. 1992 Aug 1;305(6848):310. doi: 10.1136/bmj.305.6848.310.

Misuse of ecstasy.

BMJ. 1992 Aug 1;305(6848):309. doi: 10.1136/bmj.305.6848.309.

The agony and the ecstasy: acute urinary retention after MDMA abuse.

BJU Int. 2003 Jan;91(1):123. doi: 10.1046/j.1464-410x.2003.04018.x.

Misuse of ecstasy.

BMJ. 1992 Aug 1;305(6848):309-10. doi: 10.1136/bmj.305.6848.309-b.

[Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].

Nervenarzt. 1997 Nov;68(11):922-3.

引用本文的文献

Ecstasy (MDMA) and its effects on kidneys and their treatment: a review.

Iran J Basic Med Sci. 2016 Nov;19(11):1151-1158.

Nephrotoxic effects of designer drugs: synthetic is not better!

Nat Rev Nephrol. 2014 Jun;10(6):314-24. doi: 10.1038/nrneph.2014.44. Epub 2014 Mar 25.

Urological complications of illicit drug use.

Nat Rev Urol. 2014 Mar;11(3):169-77. doi: 10.1038/nrurol.2014.22. Epub 2014 Feb 18.

Neurogenic bladder and chronic urinary retention associated with MDMA abuse.

J Med Toxicol. 2008 Jun;4(2):106-8. doi: 10.1007/BF03160964.

Drug-induced urinary retention: incidence, management and prevention.

Drug Saf. 2008;31(5):373-88. doi: 10.2165/00002018-200831050-00002.

Spontaneous versus precipitated AUR: the same?

World J Urol. 2006 Sep;24(4):354-9. doi: 10.1007/s00345-006-0089-8.

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

Drug Saf. 1996 Aug;15(2):107-15. doi: 10.2165/00002018-199615020-00003.

本文引用的文献

Subjective reports of the effects of MDMA in a clinical setting.

J Psychoactive Drugs. 1986 Oct-Dec;18(4):319-27. doi: 10.1080/02791072.1986.10472364.

Bladder outflow obstruction secondary to intravenous amphetamine abuse.

Br J Urol. 1989 Sep;64(3):320-1. doi: 10.1111/j.1464-410x.1989.tb06028.x.

'Designer drugs'. Recognizing and managing their toxic effects.

Postgrad Med. 1992 Jun;91(8):169-71, 175-6. doi: 10.1080/00325481.1992.11701371.

Ecstasy and the dance of death.

BMJ. 1992 Jul 4;305(6844):5-6. doi: 10.1136/bmj.305.6844.5.